SCHEMBL30456862

SCHEMBL30456862

ON=CC(c1ccccc1)(c1ccccc1)c1ccccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 3/20 0.47
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
OPRK1 P41145 2/20 0.40
KCNH2 Q12809 2/20 0.40
ADRA1A P35348 1/20 0.40
KCNA3 P22001 2/20 0.37
TSHR P16473 3/20 0.36
CYP3A4 P08684 2/20 0.36
CYP19A1 P11511 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 2/20 0.36
CYP1A2 P05177 2/20 0.36
SLC22A1 O15245 1/20 0.36
NR1I2 O75469 1/20 0.36
GMNN O75496 1/20 0.36
USP2 O75604 1/20 0.36
TRPM2 O94759 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3522896 1.00 KCNN4 (0.47) KCNN4HTR2AHTR2COPRK1KCNH2
SCHEMBL3522893 1.00 KCNN4 (0.47) KCNN4HTR2AHTR2COPRK1KCNH2
SCHEMBL3527440 0.78 KCNN4 (0.43) KCNN4HTR2AHTR2COPRK1KCNH2
SCHEMBL3522115 0.76 KCNN4 (0.52) KCNN4HTR2AHTR2COPRK1KCNH2
SCHEMBL27183395 0.76 KCNN4 (0.57) KCNN4HTR2AHTR2COPRK1KCNH2
SCHEMBL1871740 0.71 KCNN4 (0.47) KCNN4HTR2AHTR2COPRK1KCNH2
SCHEMBL6369689 0.69 KCNN4 (0.57) KCNN4HTR2AHTR2COPRK1KCNH2
SCHEMBL30114522 0.69 CYP3A4 (0.60) KCNN4HTR2AHTR2COPRK1KCNH2
SCHEMBL2131459 0.69 CYP3A4 (0.60) KCNN4HTR2AHTR2COPRK1KCNH2
SCHEMBL8157067 0.68 KCNN4 (0.61) KCNN4HTR2AHTR2COPRK1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4181908-A2 COMPOSITIONS COMPRISING GARDOS CHANNEL ANTAGONISTS AND THEIR USES Adimabio LLC (US) 2023-05-24 EP claimed